299 related articles for article (PubMed ID: 27664327)
1. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J
J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327
[TBL] [Abstract][Full Text] [Related]
2. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
3. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
[TBL] [Abstract][Full Text] [Related]
4. Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.
Chaowanachan T; Krogstad E; Ball C; Woodrow KA
PLoS One; 2013; 8(4):e61416. PubMed ID: 23630586
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids.
Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA
J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073
[TBL] [Abstract][Full Text] [Related]
6. FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir.
Bunge KE; Dezzutti CS; Hendrix CW; Marzinke MA; Spiegel HML; Moncla BJ; Schwartz JL; Meyn LA; Richardson-Harman N; Rohan LC; Hillier SL
J Int AIDS Soc; 2018 Aug; 21(8):e25156. PubMed ID: 30101439
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis.
Date AA; Shibata A; Goede M; Sanford B; La Bruzzo K; Belshan M; Destache CJ
Antiviral Res; 2012 Dec; 96(3):430-6. PubMed ID: 23041201
[TBL] [Abstract][Full Text] [Related]
8. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
Zhang T; Sturgis TF; Youan BB
Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
[TBL] [Abstract][Full Text] [Related]
9. Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine.
Cautela MP; Moshe H; Sosnik A; Sarmento B; das Neves J
Eur J Pharm Biopharm; 2019 May; 138():3-10. PubMed ID: 29408341
[TBL] [Abstract][Full Text] [Related]
10. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model.
Destache CJ; Mandal S; Yuan Z; Kang G; Date AA; Lu W; Shibata A; Pham R; Bruck P; Rezich M; Zhou Y; Vivekanandan R; Fletcher CV; Li Q
Antimicrob Agents Chemother; 2016 Jun; 60(6):3633-9. PubMed ID: 27044548
[TBL] [Abstract][Full Text] [Related]
11. Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides.
das Neves J; Sarmento B
Acta Biomater; 2015 May; 18():77-87. PubMed ID: 25700657
[TBL] [Abstract][Full Text] [Related]
12. Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema.
Melo M; Nunes R; Sarmento B; das Neves J
Biomater Sci; 2019 Sep; 7(9):3801-3811. PubMed ID: 31237275
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).
Robinson JA; Marzinke MA; Fuchs EJ; Bakshi RP; Spiegel HML; Coleman JS; Rohan LC; Hendrix CW
J Acquir Immune Defic Syndr; 2018 Feb; 77(2):175-182. PubMed ID: 29135651
[TBL] [Abstract][Full Text] [Related]
14. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
Akil A; Devlin B; Cost M; Rohan LC
Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
[TBL] [Abstract][Full Text] [Related]
15. Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles.
Lakshmi YS; Kumar P; Kishore G; Bhaskar C; Kondapi AK
Sci Rep; 2016 May; 6():25479. PubMed ID: 27151598
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.
Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA
Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice.
das Neves J; Araújo F; Andrade F; Amiji M; Bahia MF; Sarmento B
Pharm Res; 2014 Jul; 31(7):1834-45. PubMed ID: 24449442
[TBL] [Abstract][Full Text] [Related]
18. Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates.
Koehn J; Iwamoto JF; Kraft JC; McConnachie LA; Collier AC; Ho RJY
AIDS; 2018 Nov; 32(17):2463-2467. PubMed ID: 30102655
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
20. Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.
Srinivasan P; Zhang J; Martin A; Kelley K; McNicholl JM; Buckheit RW; Smith JM; Ham AS
Antimicrob Agents Chemother; 2016 Jul; 60(7):4140-50. PubMed ID: 27139475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
